Ads
related to: experimental treatment for rectal cancer
Search results
Results From The WOW.Com Content Network
A new treatment for locally advanced rectal cancer (LARC) reduced the existence of tumors by twice the amount as previous approaches, eliminating the need for surgery, a new study found.
In the U.S., Keytruda is approved for patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer. Keytruda has not been ...
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
Zabadinostat is an experimental epigenetic drug being investigated as a potential treatment for advanced or metastatic cancers. It is an orally available Class I selective histone deacetylase (HDAC) inhibitor, with half maximal inhibitory concentrations (IC 50) of 62 nM, 570 nM and 550 nM, against HDAC1, HDAC2 and HDAC3, respectively.
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer. [2] Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion .
Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to access to more effective medications and better awareness about the Fighting Cancer: Colorectal Cancer's ...
Ads
related to: experimental treatment for rectal cancer